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ABSTRACT 
Introduction 
Although a pathological nipple discharge can be associated with breast cancer, most 
of the causes are benign. The current gold standard for diagnosis is 
microdochectomy and this means that many women will undergo this invasive 
procedure for benign causes. Demographic data of patients, clinical characteristics, 
and preoperative radiological investigations which can select patients at risk of 
cancer may help to reduce the number of patients operated for benign causes but 
there is little data to confirm this, especially from sub-Saharan Africa. 
Aim 
This study aimed to determine the prevalence of cancer in patients who had 
microdochectomy for pathological nipple discharge in a population in South Africa 
and evaluate patients’ demographics and clinical characteristics as indicators of 
underlying cancer.  
Patients and methods 
Clinical, radiological and histological data from 153 patients who underwent a 
microdochectomy for a pathological nipple discharge at two South African breast 
clinics was collected. 
Results 
Invasive or in-situ cancer was found in 12 patients (7.84%) and in all patients, cancer 
was associated with a bloody nipple discharge. Bloody discharge had a sensitivity of 
100% in indicating cancer, specificity of 55.32%, positive predictive value of 16%, 
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and negative predictive value of 100%. Patients with breast cancer were also more 
likely to be above 50 years (p=0.04). Preoperative mammogram and ultrasound were 
poor in detecting cancer (0/12). 
Conclusion 
In our population, patients with an isolated bloody nipple discharge (no mass) should 
have microdochectomy done, while many other patients can be managed 
expectantly with surgery only offered in individualised cases. Thorough clinical 
examination to determine the true colour and nature of the discharge is vital in the 
initial assessment of these patients. Preoperative radiology is not helpful in 
determining the presence of cancer (in an isolated pathological nipple discharge) 
and microdochectomy still remains the gold standard in diagnosing cancer in these 
patients. 
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CHAPTER 1 
 
INTRODUCTION 
A nipple discharge is the third most common cause for women presenting with 
breast complaints (1). This is an important finding because breast cancer can be the 
cause. From the literature, this incidence is up to 37.0% (2), with those with the 
highest percentage seen in patients with breast masses. In this group of patients 
with pathological nipple discharge, the diagnosis of cancer required duct excision in 
20% cases. In the largest meta-analysis involving 3110 patients with a nipple 
discharge, 18.7% had cancer as a cause (1). Nipple discharges can be separated 
into physiological or pathological. A physiological nipple discharge is often seen 
following breast manipulation, it is typically bilateral and emanates from multiple 
ducts. Its causes are mainly benign (3). Other causes of physiological nipple 
discharge are idiopathic, pituitary adenoma, hypothyroidism, ectopic prolactin 
production, hypothalmic disorders, and medications (including some 
antidepressants, antipsychotics, and H2 antagonists). 
A pathological nipple discharge is defined by the presence of one or more of the 
following: spontaneous nipple discharge, bloody nipple discharge and/or nipple 
discharge associated with a mass or skin changes (4). It is usually unilateral, uni-
ductal and often persistent. A detailed patient history and examination can help 
separate the two types of nipple discharges.  
Patients who have cancer as a cause of pathological nipple discharge are a 
challenge to ensure timeous diagnosis for the treating physician. Most studies have 
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shown an association between cancer and a bloody nipple discharge (5,6,7), 
although this is not always the case. Two studies found no association (2,8), but 
where bloody nipple discharge was not related to cancer, the cancer prevalence was 
either very small at 2.3% (8), or predicted by a breast mass (2). Old age was also 
suggested as a predictor (8,9). A study done in Ghana, with a comparable population 
to our own, showed cancer as a cause in 2.5% of patients with bloody nipple 
discharge without palpable masses and cancer went up to 31.7% when those with 
palpable masses were include (10).   
The gold standard for diagnosis is a microdochectomy, a surgical procedure under 
general anaesthetic, that entails making a limited circumareolar incision and raising 
the areola skin flap. The discharging duct is dissected out and lacrimal probe or 
methylene blue dye can be used to help locate and follow the duct during dissection 
(11). Compared to complete sub-areolar tissue excision and mastectomy, which 
were done in the past to exclude malignancy, microdochectomy is less invasive, and 
also preserves ducts for future breast feeding in women of reproductive age (11). 
Furthermore, michrodochectomy remains the bench mark to exclude malignancy in 
patients with a pathological nipple discharge. In an attempt to avoid unnecessary 
operative procedures (including a microdochectomy), investigations can be done to 
help diagnose cancer. These include cytological investigations on the nipple 
discharge fluid including testing for occult blood, ductography, ductoscopy, as well as 
preoperative radiology such as ultrasound, mammogram, and magnetic resonance 
imaging (12,13,14), however few have been shown separately to have high 
sensitivity for predicting cancer (4,14). Mammogram,ultrasound,magnetic resonance 
imaging, and ductography had a sensitivity of 37.5%, 25.5%, 100%, 50.0% 
respectively in diagnosing malignancy (14). 
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 In another study, magnetic resonance imaging had a sensitivity of 86% to 100% in 
detecting invasive cancer and a sensitivity of 40% to 100% in detecting ductal 
carcinoma insitu.  Magnetic resonance imaging has the advantage of that it is non-
invasive, has no radiation, can help differentiate between benign and malignant 
lesions, and can help with staging once cancer has been confirmed. Its disadvantage 
is that it is not readily available, it is expensive, and requires special skill in reporting 
the films. In duct cytology, nipple aspiration and subsequent cytological analysis is 
done. Ductography entails visualisation of of the affected duct system. Distortion, 
irregular stenosis, or obstruction of the ducts may indicate the presence of 
malignancy. Ductoscopy is an endoscopic technique that is used to visualise 
mammary ducts. It can provide accurate localisation of pathology, allow biopsy of 
lesions, and also enable ductal lavage for cytological analysis.  
In Sub-Saharan Africa the implications of a surgical procedure and hospital 
admission will affect every domain of a patient’s life. They require time off from 
scarce work, travel back and forth to a hospital capable of the procedure for initial 
and follow-up visits (which may be more than 100 kilometres away), as well as the 
high costs associated with an operation. These factors reiterate the importance that 
each operation should be justifiable or unavoidable. It is vital to find preoperative 
investigations or clinical parameters that can be associated with cancer in our 
patients. The purpose of this study was to evaluate the characteristics which may 
help predict cancer in patients with a pathological nipple discharge and to potentially 
make recommendations on how to best approach these patients in a resource-
limited setting. 
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CHAPTER 2 
 
METHODS 
Patient selection 
This was a retrospective records review of female patients undergoing 
microdochectomy for pathological nipple discharge at two specialist breast care 
centres in Johannesburg, South Africa, over a five year period. Ethical approval for 
the study was obtained from the University of the Witwatersrand Human Research 
Ethics Committee (Medical) (clearance number M120974). 
Data Acquisition  
Pre-operative clinical and radiological records were reviewed in addition to patients’ 
final histological reports. Demographic data was captured from hospital records and 
clinical consultation notes indicated the characteristics of the nipple discharge. The 
radiological records included imaging results that were carried out or supervised by 
radiologists with a special interest in breast radiology, as well as noted findings 
which were discussed in a multidisciplinary team meeting consisting of breast 
surgeons, pathologists and radiologists. Patients with a known history of breast 
malignancy, palpable mass, or any other features that suggested malignancy on 
clinical examination were excluded from the study, as were patients with 
physiological nipple discharges. At the time of the study, patients with palpable 
breast masses with or without nipple discharge were investigated by biopsy and 
treated according to the biopsy findings. Patients with suspicious breast findings on 
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mammogram (i.e calcifications) had either stereotactic or hook wire guided biopsy 
and were managed according to the biopsy results. Patients with pathological nipple 
discharge without any palpable breast masses had microdochectomy done, while 
those with physiological nipple discharge were followed up and the cause of the 
discharge treated if identified. 
 
Statistical Analysis 
Data was captured into MS Excel and imported into STATISTICA 12 for data 
analyses. The clinical characteristics of the nipple discharge were separated into 
categories of bloody (including brown and sero-sanguinous), serous and opaque 
(including white, yellow and green). Serous nipple discharge consisted of serous and 
clear discharges. Patients were also split into two groups of age ≤50 years and >50 
years and analysed accordingly. Breast cancer is more prevalent in the older age 
group, especially in postmenopausal women. Fifty years was used as it is the mean 
age around which menopause starts. The imaging results were transcribed from 
free-text reports and, for the purpose of analysis, separated into groups based on the 
most common findings of retro-areolar abnormality (such as filling defects in the 
retroareolar area and lesion/papilloma in the retroareolar region), dilated ducts only 
and no significant abnormality. Histology was reported categorically as either 
Cancer, Benign papilloma, Duct ectasia, or Other: Cancer included premalignant 
lesions and invasive cancer; Duct ectasia included duct ectasia, ductal hyperplasia, 
duct ectasia and apocrine metaplasia; Benign papilloma consisted of benign 
papilloma, papillomatosis, and ductal papillomas; and, Other included non-specific 
pathology, fibrocystic change, inflammation, and tuberculosis. The relationship 
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between each nipple discharge and imaging category and their risk of cancer was 
analysed statistically. 
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CHAPTER 3 
 
RESULTS 
A total of 153 women underwent microdochectomy during the study period at any of 
the two study centres. The ages of the patients ranged between 20 and 80 years 
with a mean (±SD) age of 51.4 (13.5) years of which 45% (n=69) were aged less 
than or equal to 50.0 years. The patient demographics, clinical characteristics and 
radiology findings (mammogram and ultrasound) are shown according to histology in 
Table 1. The most common histopathological finding was benign papilloma in 87 
patients (56.9%). Cancer was found in 12 women (7.8%), of which five patients had 
invasive cancer (3.3% of total cohort) and the remaining seven cancer patients had 
ductal carcinoma in-situ (4.6% of total cohort). Moreover, in the five patients with 
invasive cancers, three patients had ductal carcinoma, one patient had intra-cystic 
papillary carcinoma and the remaining patient had a tubular carcinoma. As could be 
expected, the cancer patients (n=12) were significantly older than those without 
cancer (n=141) with mean ages of 59.3 years and 50.7 years, respectively (P=0.04). 
However, of the 12 cancer patients, three patients were in the age category ≤50 
years and no association was found between these age categories and prevalence 
of cancer. However, when we increased the cut-off in the age category to ≤55 years, 
a significant difference was found (Table 1). 
When investigating the nipple discharge colour in this study population, a bloody 
nipple discharge was reported in 49% of patients, a serous nipple discharge in 
another 49% and opaque nipple discharge in the remaining 2%. Notably, women 
with a bloody nipple discharge were significantly older than those with a serous 
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nipple discharge (54.1 and 48.8 years, respectively; P=0.02). All cancer patients in 
this study reported a bloody nipple discharge, while the majority of patients with 
benign papilloma (n=47, 54.0%), duct ectasia (n=14, 50%) or other histological 
findings (n=14, 53.8%) reported a serous nipple discharge (Table 1). When 
compared to a serous nipple discharge alone, a bloody nipple discharge was 
significantly associated with having cancer in our study population (P=0.001).   
Mammographic and ultrasound (US) imaging results were available for all patients in 
this study population. The most common mammographic finding was no abnormality 
for all of the histology groups. Specifically in the cancer group, half of patients had a 
no abnormality (n=6), 33.3% showed retro-areolar abnormalities (n=4) and the 
remaining 16.7% (n=2) showed dilated ducts.  Furthermore, one cancer patient had 
a normal ultrasound, whereas 50.0% showed dilated ducts and the remaining 41.7% 
showed a retro-areolar abnormality with ultrasound. Only three cancer patients 
(25%) had retro-areolar abnormalities in both mammogram and ultrasound findings. 
There was no significant relationship between cancer diagnosis and any radiological 
imaging results. The sensitivity of mammographic imaging in identifying pathology 
was 32% compared to 63.4% for ultrasound imaging. Ultrasound imaging of the 87 
patients with benign papilloma showed retro-areolar abnormality in 30 patients 
(34.5%). In the 28 patients with ducts ectasia, ultrasound imaging showed dilated 
ducts in 16 patients (57.1%). 
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CHAPTER 4 
 
DISCUSSION 
In this study of women treated in two South African hospitals with a pathological 
nipple discharge undergoing microdochectomy, the incidence of cancer was 7.8%. 
This falls within the range of up to 37.0% quoted in the literature (2). The study that 
quoted 37.0% included patients who also had a breast mass (2), which were 
excluded in this study. In this group of patients with pathological nipple discharge, 
the diagnosis of cancer required duct excision in 20% cases. Similar to other studies, 
benign papilloma was the commonest cause of a pathological nipple discharge in our 
study population at 56.9% (2,7,15). In this study, patients with breast cancer were 
older compared to patients in the other pathology groups. This reached significance 
when the non-cancer pathologies were grouped together.  
The association between breast cancer and a bloody nipple discharge is well 
documented in the literature with the few studies that  failed to show this association 
had either low prevalence of cancer or breast masses present (2,8). In this current 
study, the presence of a bloody nipple discharge was associated to breast cancer. 
Notably, where all cancer patients reported a bloody nipple discharge, they made up 
only 16% of those with a bloody nipple discharge. Furthermore, patients with a 
bloody nipple discharge were significantly older than those with a serous nipple 
discharge. A bloody nipple discharge had a sensitivity of 100% for cancer, with a 
negative predictive value (NPV) of 100% and this combination of a bloody nipple 
discharge and age as risk factors for cancer in this study would support the notion 
that, in patients with bloody nipple discharge over the age of 50 years, a 
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microdochectomy should be performed even though a negative finding can be 
expected in two-thirds of patients. More evident from our study is the NPV of 100% 
for cancer if there is no bloody nipple discharge. This finding, which is supported in 
some studies (7,15), should give the breast clinician confidence to recommend close 
surveillance of a serous nipple discharge rather than immediate microdochectomy. 
Moreover, this has an important implication for resource-limited settings with similar 
patient groups as it would immediately reduce the rate of microdochectomies by 
50%.  
This study concurs previous findings that pre-operative imaging with mammogram 
and ultrasound is not helpful in diagnosing cancer in patients with pathological nipple 
discharge (6,8,16).  Sensitivity of a mammogram in elucidating any pathology in this 
study group was also poor (32%) and this too has been documented in the literature 
(6,7,16). Ultrasound imaging was more successful than mammography at detecting 
subtle changes such as retroareolar abnormalities and dilated ducts. It should be 
noted that our study was limited to patients requiring a microdochectomy for 
diagnosis, and therefore there may be a bias away from patients with a pathological 
nipple discharge and obvious lesion that could be percutaneously biopsied. 
Mammogram and ultrasound imaging do have a role in detecting other pathologies 
both in the presence of a nipple discharge and in the contralateral one, and for this 
reason they should always be done in patients with a pathological nipple discharge.  
Other preoperative investigative modalities have been studied in the past and have 
also shown disappointing results.  Cytology, ductoscopy and galactography have all 
shown poor sensitivity for cancer and thus cannot be used to diagnose cancer in 
pathological nipple discharge patients (17,18,19). Magnetic resonance imaging 
should be studied more as it has shown promising results in some studies 
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(13,20,21). Immune clinical studies also have to be studied further to see if they can 
diagnose cancer and help reduce the number of patients who undergo surgery 
unnecessarily (1).  Immune clinical studies involves the detection of nipple discharge 
autoantibodies against tumour antigens. Examples of these are CA15-3, CA125 and 
CEA. Their role in further examination of the nipple discharge fluid is promising and 
need to be studied further. This study and other studies done before have shown 
that microdochectomy still remains the gold standard in diagnosing cancer and other 
pathologies in patients with pathological nipple discharge.  
Another important limitation of this study is the retrospective nature, and therefore a 
reliance on clinical notes of the nipple discharge colour with no uniformity regarding 
the classification of colour. Whilst it would not be clinical good practice to carry out a 
prospective study operating on every pathological nipple discharge, the authors 
stress the importance of good surveillance and follow-up of any patients with a nipple 
discharge. In a resource-limited setting this is even more important as patients may 
not wish to come back, and education has a role to play in aiding patients to 
understand their disease. Determining the role of a microdochectomy for symptom 
control and comfort in a resource-limited setting is beyond the scope of this paper, 
but should be considered. 
 
Conclusion 
The findings from this study show that microdochectomy remains the gold standard 
in diagnosing cancer in women with a pathological nipple discharge. The prevalence 
of malignancy in patients who had microdochectomy for a pathological nipple 
discharge was 7.8% and benign papilloma was the most common histopathological 
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finding. Preoperative radiological investigations were inaccurate in diagnosing 
significant pathology in patients with pathological nipple discharge. However, simple 
steps can help reduce the burden of operative requirements in these patients. Step 
one is a good history and clinical examination to determine the age and the true 
colour or nature of the nipple discharge. Step two is adequate experienced breast 
imaging (defined to mean breast imaging done by a radiologist with experience in 
performing and interpreting breast images using different imaging modalities) to 
reduce the number of patients who remain undiagnosed non-invasively. Step three is 
microdochectomy of patients with bloody nipple discharge and age above 55 years 
and selective microdochectomy for those with bloody discharge and aged 55 years 
and below, with good education and close follow-up of all other women with a nipple 
discharge. 
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Table 1. Patient demographics, clinical characteristics and radiological findings according to histology 
Demographic data Cancer Benign 
papilloma 
Duct Ectasia Other ALL  P-value:  
Ca vs No Ca 
 n (% of all) 12 (7.8%) 87 (56.9%) 28 (18.3%) 26 (17.0%) 153 (100%)  
Continuous variable*       
Mean age (years) 59.3 ± 13.3  51.5 ± 12.2  47.9 ± 13.3  51.1 ± 16.7  51.4 ± 13.5 0.04 
Categorical variables**       
Age ≤ 50 years 3 (25.0%) 38 (43.7%) 16 (57.1%) 12 (46.2%) 69 (45.1%) 0.1 
Age ≤ 55 years 4 (33.3%) 55 (63.2%) 21 (75.0%) 18 (69.2%) 98 (64.1%) 0.03 
Nipple discharge colour      0.02 
     Bloody 12 (100%) 38 (43.7%) 13 (46.4%) 12 (46.2%) 75 (49.0%)  
     Serous 0  47 (54.0%) 14 (50%) 14 (53.8%) 75 (49.0%)  
     Opaque 0 2 (2.3%) 1 (3.6%) 0  3 (2.0%)  
Mammogram      0.4 
     Retro-areolar abnormality 4 (33.3%) 14 (16.1%) 3 (10.7%) 5 (19.2%) 26 (17.0%)  
     Normal 6 (50.0%) 61 (70.1%) 19 (67.9%) 18 (69.2%) 104 (68.0%)  
     Dilated ducts 2 (16.7%) 12 (13.8%) 6 (21.4%) 3 (11.5%) 23 (15.0%)  
Ultrasound      0.3 
     Retro-areolar abnormality 5 (41.7%) 30 (34.5%) 3 (10.7%) 6 (23.1%) 42 (27.5%)  
     Normal 1 (8.3%) 35 (40.2%) 9 (32.1%) 11 (42.3%) 56 (36.6%)  
     Dilated Ducts 6 (50.0%) 22 (25.3%) 16 (57.1%) 9 (34.6%) 53 (34.6%)  
*Value ± SD; **Number of patients n (% of group total); Ca: Cancer.  
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1. Full Title 
Prevalence of breast cancer in patients undergoing microdochectomy for a 
pathological nipple discharge. 
 
2. Introduction 
Following only breast pain and breast lumps, nipple discharge is the third most 
common presentation seen in patients with breast disease presenting to breast 
surgical units. It also accounts for approximately 5 % of all referrals to breast 
units (1). About 80% of females will experience at least one episode of nipple 
discharge during their reproductive years (1). Nipple discharge is defined as the 
passage of liquid material through the nipple, either spontaneously or with 
manipulation of breast tissue (1). It is mostly caused by benign conditions, but in 
a small percentage of patients (10-15 %) the cause is an underlying malignancy 
(1). This small percentage of patients who can have malignancy as the 
underlying cause of nipple discharge, pose a challenge to the treating surgeon 
as neither the clinical predictors of malignancy nor preoperative  investigations 
can reliably distinguish between benign and malignant pathology. 
Nipple discharge can be classified into either physiological and benign or 
pathological and suspicious (2). The colour of the discharge can be of several 
types: 1) milky, 2) multi-coloured and sticky, 3) purulent, 4) clear and watery, 5) 
yellow or serous, 6) pink and serosanguinous, or 7) bloody or sanguinous (1). 
Studies have shown that pathological nipple discharge is characterised by being 
spontaneous, unilateral, uniductal, persistent, and bloody. In contrast, 
physiological nipple discharge, which is often a feature following breast 
manipulation, is typically considered bilateral and emanating from multiple ducts 
(1-7). 
The causes of nipple discharge include carcinoma, fibrocystic lesions, 
inflammation, duct ectasiae, and papilloma. Such carcinomas include invasive 
cancers, ductal carcinoma in situ, high risk lesions, lobular carcinoma in situ and 
atypia (2). Moreover, papilloma is the most common pathological finding in 
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patients with pathological nipple discharge, accounting for 40% to 70% of cases 
(4).  
While patients with physiological nipple discharge are managed conservatively, 
those with pathological discharge are best managed with microdochectomy, the 
latter of which is both diagnostic and therapeutic (3).Patients who present with 
pathological nipple discharge are evaluated by a thorough history and physical 
examination, preoperative investigations, and microdochectomy. The patient’s 
history is recorded to include the colour of the discharge, the period of the 
discharge, previous history of breast disease, medications, and other associated 
symptoms. The physical examination will focus on a routine breast examination 
which includes looking at nipple discharge if present at that time, nipple 
inversion, skin dimpling and changes, breast lumps and axillary lymph nodes. All 
patients with pathological nipple discharge should have mammography and 
ultrasonography done. This enables the identification of a lesion responsible for 
the discharge if present, however it fails to reliably differentiate between benign 
and malignant lesions. In addition, other breast pathology that is unrelated to the 
discharge may be identified. With regards to nipple discharge, studies have 
shown that mammogram and ultrasound sensitivities are low at 60% and 65%, 
respectively (2,3), and thus their use as screening tools in the assessment of 
nipple discharge are limited. Furthermore, mammograms have a high negative 
predictive value and specificity, suggesting that, in the setting of physiological 
nipple discharge, it can be used to select and follow up patients for whom clinical 
observation alone is a reasonable management approach. 
Other preoperative investigations include cytology, ductography, ductoscopy and 
immune clinical studies. In duct cytology, nipple aspiration and subsequent 
cytological analysis is done. The latter has been shown to be a poor indicator of 
underlying malignancy in nipple discharge (50%sensitivity)(3). It is therefore not 
widely used as it can miss up to 50% of malignancies. 
A ductography is good for visualisation of the affected duct system in patients 
with pathologic nipple discharge. It can identify intraductal papillomas which are 
demonstrated by filling defects within the dilated ducts while solitary papillomas 
are seen in the collecting ducts. Multiple papillomas are seen in branching ducts. 
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Distortion, narrowing, or obstruction of the ducts may indicate the presence of 
malignancy (4). The disadvantage of the procedure is that it is painful and is 
limited in detecting lesions that do not fully obstruct the ductal lumen or in 
detecting multiple lesions in the same duct. Due to these reasons, it is rarely 
used in the evaluation of patients with spontaneous nipple discharge.  
Ductoscopy is an endoscopic technique that is used to visualise mammary 
ducts. It has been evolving over the last 15 years and unlike ductography, it can 
provide accurate localisation of the pathology and also enable ductal lavage for 
cytological analysis. This increases the cytological yield when compared to 
simple discharge cytology (can increase by 100 fold) (4). The disadvantage of 
the technique is that it is not widely used, it is expensive, and has limited 
expertise. 
Microdochectomy remains the gold standard to exclude malignancy in patients 
with pathological nipple discharge as clinical examination and preoperative 
studies can only identify patients with pathological discharge but cannot confirm 
malignancy. In the last 30 years, this conservative approach to patients with 
pathological nipple discharge has become accepted, as compared to the radical 
procedures used more than 50 years ago (4). A limited circum-areolar incision is 
made and the areola skin flap is raised. The discharging duct is dissected out 
and lacrimal probe or methylene blue dye can be used to help locate and follow 
the duct during dissection. Compared to complete subareolar tissue excision, 
microdochectomy is preferred as it is less invasive and also preserves ducts for 
future breast feeding in women in the reproductive age group. 
From the literature it is evident that there is an association between pathological 
nipple discharge and underlying malignancy, with the incidence of malignancy in 
these patient groups ranging from 7% to 33% (2). This is a high percentage 
variation and would lead to microdochectomy being recommended for all 
patients with pathological nipple discharge to exclude malignancy. Also, it is 
known that a bloody nipple discharge could be a predictor of breast cancer risk. 
Clinical examination and preoperative evaluation of patients with pathological 
nipple discharge cannot reliably distinguish between benign and malignant 
causes. (1-7) 
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Published data on the prevalence and causes of pathological nipple discharge 
from South Africa is lacking. Therefore, the purpose of this study is to determine 
the prevalence of malignancy in patients who had microdochectomy for a 
pathological nipple discharge in two hospitals in Johannesburg, South Africa. 
This will enable us to compare our local population’s prevalence to that of other 
international studies. The study will also determine the common causes of 
pathological nipple discharge in our local setting and enable the evaluation of the 
accuracy of preoperative radiological investigations in identifying significant 
pathology. Furthermore, any trend seen from the radiological investigations with 
regards to pathological nipple discharge could initiate prospective studies to 
investigate better tools for future diagnosis. 
 
3. Study objectives 
Primary endpoints 
- To determine the prevalence of malignancy in patients who had 
microdochectomy for  pathological nipple discharge. 
 
- To determine common causes of pathological nipple discharge in our 
population setting. 
 
Secondary endpoints 
- To evaluate the accuracy of preoperative radiological investigations in the 
diagnosis of significant pathology in patients with pathological nipple discharge. 
 
4. Methods 
This is a retrospective analysis of all patients who had a microdochectomy done 
for a pathological nipple discharge at Helen Joseph Hospital Breast Unit and 
Milpark Hospital Breast Unit( Johannesburg, South Africa), over a 5 year period 
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between June 2007 and June 2012. Helen Joseph Hospital is a Government 
Hospital that mainly attends to patients without medical aid while Milpark 
Hospital sees private patients. The operations in both hospitals were done by the 
same team of surgeons. 
Histopathological and preoperative radiological (mammogram and ultrasound) 
reports will be reviewed. Also patients’ demographics will be included in the data 
collection. 
Inclusion criteria 
-all female patients who underwent microdochectomy for a pathological nipple 
discharge during the study period. 
-patients who had both mammogram and or ultrasound investigations 
preoperatively. 
 
Exclusion criteria 
-patients with known breast malignancy  
 
 
Study procedures 
Patient data will be collected anonymously from histopathology and radiology 
records. The data will be analysed and variables recorded from both histology 
and radiology reports. 
 
Data collection 
Data will be collected by the candidate, with assistance from the breast 
surgeons. The data will include; 
-name, age, gender, and medical history of patient 
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-histopathology reports from microdochectomy procedure 
-preoperative mammogram and ultrasound reports 
 
5. Data Analysis 
Data collected will be entered into Excel spreadsheet and data analysed in 
statistica. Results will be presented in tables and graphs expressed as mean ± 
standard deviation and frequency (n). Where groups are compared, this will use 
a student t-test or non-parametric test, e.g. Mann-Whitney. 
 
6. Ethics 
Ethics application will be submitted to Human Research Ethics Committee of the 
University of the Witwatersrand in September 2012. 
 
 
7. Timing 
 Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr 
Literature review           
Preparing protocol           
Protocol assessment           
Ethics application           
Collecting data           
Data analysis           
Writing up thesis           
Submission           
 
8. Funding 
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No funding required. Stationary costs will be covered by the Department of 
Surgery, University of the Witwatersrand. 
9.  Problems/Challenges 
Inability to access all the data required. This will be reviewed and inadequate 
data might lead to patients being excluded from the study. 
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APPENDIX 2: Data recording sheet 
 
DATA RECORDING SHEET  “Prevalence of breast cancer in patients 
undergoing microdochectomy for a pathological nipple discharge” 
 
Patient identification number:__________________ 
 
Age (years):_______ 
 
Symptoms;__________________________________ 
 
Nipple discharge side (R/L):_____________________ 
    -Colour of discharge:_________________________ 
 
Operation: Unilateral/Bilateral; _________________ 
 
Place of operation;____________________________ 
 
Histology report; 
 -Invasive cancer:_______________________ 
 -Ductal carcinoma in situ:________________ 
 -Lobular carcinoma in situ:_______________ 
 -Atypia:______________________________ 
 -Benign papilloma:_____________________ 
 -Benign duct ectasia:___________________ 
 -Benign nonspecific changes:_____________ 
 -Others (specify):______________________ 
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Breasts Ultrasound report; 
 -Normal:___________ 
 -Abnormal (Specific 
findings):_____________________________________________ 
 
Mammogram report; 
 -Normal:___________ 
 -Abnormal (Specific 
findings):_____________________________________________ 
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APPENDIX 3: Ethics clearance 
 
